Details of issuance or disposal
Monthly exercise status of the Series 6 Stock Acquisition Rights, Series 1 Unsecured Convertible Bonds with Stock Acquisition Rights and Series 7 Stock Acquisition Rights (with Exercise Price Adjustment Provisions) issued through a third-party allotment
Shares delivered during the month under review: 86,700 shares (Series 7 Stock Acquisition Rights). The Series 1 Unsecured Convertible Bonds with Stock Acquisition Rights and Series 6 Stock Acquisition Rights: 0 shares.
2.98% (86,700 shares delivered during the month under review for all series combined / 2,911,799 shares outstanding as of the payment date for the issuance)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
| Item | Details |
|---|---|
| Type of issuance or disposal | Monthly exercise status of the Series 6 Stock Acquisition Rights, Series 1 Unsecured Convertible Bonds with Stock Acquisition Rights and Series 7 Stock Acquisition Rights (with Exercise Price Adjustment Provisions) issued through a third-party allotment |
| Number of shares to be issued or disposed of | Shares delivered during the month under review: 86,700 shares (Series 7 Stock Acquisition Rights). The Series 1 Unsecured Convertible Bonds with Stock Acquisition Rights and Series 6 Stock Acquisition Rights: 0 shares. |
| Intended allottee | GP上場企業出資投資事業有限責任組合 (allottee at the time of the previous issuance) |
| Dilution Rate | 2.98% (86,700 shares delivered during the month under review for all series combined / 2,911,799 shares outstanding as of the payment date for the issuance) |
| Total number of issued shares | 2,911,799 shares (as of the end of the month preceding the month under review) → Not disclosed |
| Exercise price | Series 7 Stock Acquisition Rights: ¥216, ¥207, ¥177 and ¥164 (exercise price on each exercise date). Details of the adjustment provisions and the adjustment floor: Not disclosed. |
| Number of Stock Acquisition Rights | Series 7 Stock Acquisition Rights: total issued, 20,051; unexercised at the end of the month under review, 19,184; exercised during the month under review, 867. Series 6 Stock Acquisition Rights: unexercised at the end of the month under review, 9,588. |
| Procedures under the Corporate Code of Conduct | Disclosure of compliance with the exercise restrictions under Article 434 of the Tokyo Stock Exchange Securities Listing Regulations and the Japan Securities Dealers Association Rules Concerning the Handling of Third-Party Allotments, etc. |
| Most recent equity financing | 14 April 2025 issuance: Series 6 Stock Acquisition Rights and Series 1 Unsecured Convertible Bonds with Stock Acquisition Rights; amount: Not disclosed, 15 June 2026 issuance: Series 7 Stock Acquisition Rights (with Exercise Price Adjustment Provisions); amount: Not disclosed |
Items this document does not state (19)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The monthly exercise status is being disclosed because, following the issuance of the Series 7 Stock Acquisition Rights, the Series 6 Stock Acquisition Rights and Series 1 Unsecured Convertible Bonds with Stock Acquisition Rights are deemed to constitute “MSCBs, etc.” under the rules of the Tokyo Stock Exchange.